← Leaderboards
Peter A Anton
University Of California Los Angeles
$8,396,612
Attributed
$10,919,688
Total exposure
16
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$30,044,176 · 17
By mechanism
U19$21,230,550 · 7
R01$5,932,943 · 3
P30$1,826,408 · 3
K24$636,493 · 1
R56$361,695 · 1
M01$56,087 · 2
Top collaborators
- Otto O Yang5 shared
- Grace M. Aldrovandi4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ian Michael McGowan$58,156,521
- Anne-Marie Corner$3,144,364
- Jamie Feusner$10,846,177
- Ivanka Savic-Berglund$1,314,550
- Ronald T Mitsuyasu$121,811,876
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsHuman SubjectMucous MembraneMicrobicideResearch PersonnelPathogenesisImmunologyBiopsyTissuesResourcesSiteInterestAids PreventionAreaClinical TrialsFosteringInfectionCohortChemokineCellsPreventionMucosal SiteApplications GrantsBase
Grant awards (54)
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$570,239
R01 · FY2020 · AI
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$593,733
R01 · FY2019 · AI
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$582,527
R01 · FY2018 · AI
Administrative and Bioinformatics Core$385,622
U19 · FY2018 · AI · contact PI
Mucosal Immunology Core$118,848
P30 · FY2018 · AI · contact PI
Maturation, Infectibility, and Trauma(MIT) Contributes to HIV Susceptibility in Adolescents$632,229
R01 · FY2017 · AI
Topical Microbicides: Targeted Intracellular Delivery$558,194
R01 · FY2017 · AI
Administrative and Bioinformatics Core$365,023
U19 · FY2017 · AI · contact PI
Mucosal Immunology Core$176,026
P30 · FY2017 · AI · contact PI
Topical Microbicides: Targeted Intracellular Delivery$567,742
R01 · FY2016 · AI
Administrative and Bioinformatics Core$318,140
U19 · FY2016 · AI · contact PI
Mucosal Immunology Core$176,175
P30 · FY2016 · AI · contact PI
Topical Microbicides: Targeted Intracellular Delivery$581,481
R01 · FY2015 · AI
Administrative and Bioinformatics Core$341,468
U19 · FY2015 · AI · contact PI
Mucosal Immunology Core$176,387
P30 · FY2015 · AI · contact PI
Topical Microbicides: Targeted Intracellular Delivery$598,312
R01 · FY2014 · AI
Administrative and Bioinformatics Core$285,125
U19 · FY2014 · AI · contact PI
Mucosal Immunology Core$181,453
P30 · FY2014 · AI · contact PI
Mucosal Immunology Core$176,373
P30 · FY2013 · AI · contact PI
Mechanistic Studies of HIV-exposed Seronegative Individuals$361,695
R56 · FY2012 · AI
Mucosal Immunology Core$86,652
P30 · FY2012 · AI · contact PI
Mucosal Immunology Core$137,643
P30 · FY2011 · AI · contact PI
Mucosal Immunology Core$69,313
P30 · FY2010 · AI · contact PI
Microbicide Development Program (MDP)$2,071,249
U19 · FY2009 · AI · contact PI
Microbicide Development Program (MDP)$121,998
U19 · FY2009 · AI · contact PI
Exploratory human trials of rectal microbicides$121,998
U19 · FY2009 · AI · contact PI
Regulatory compliance and human subjects safety$91,565
U19 · FY2009 · AI · contact PI
Administrative$80,728
U19 · FY2009 · AI · contact PI
Mucosal Immunology Core$65,200
P30 · FY2009 · AI · contact PI
Data management and biostatistics$62,671
U19 · FY2009 · AI · contact PI
Microbicide Development Program (MDP)$4,184,742
U19 · FY2008 · AI · contact PI
Mucosal Immunology Core$60,500
P30 · FY2008 · AI · contact PI
Microbicide Development Program (MDP)$3,919,435
U19 · FY2007 · AI · contact PI
Microbicide Development Program (MDP)$2,449,845
U19 · FY2006 · AI · contact PI
Compartment-specific topical microbicide formulations$1,532,045
U19 · FY2006 · AI · contact PI
Core A - Administrative$53,722
U19 · FY2006 · AI · contact PI
Microbicide Development Program (MDP)$2,415,234
U19 · FY2005 · AI
ROLE OF SITE OF IMMUNIZATION IN ELICITING MUCOSAL IMMUNITY -ALVAC HIV (VCP205$47,400
M01 · FY2005 · RR
A NOVEL PRE-CLINICAL MUCOSAL IMMUNIZATION AGAINST HIV-1: HIV SERONEGATIVE PAR$658
M01 · FY2005 · RR
Microbicide Development Program (MDP)$2,429,940
U19 · FY2004 · AI
Role of Immunization Site in Eliciting Mucosal Immunity$141,715
R01 · FY2004 · AI
IMPACT OF CO-RECEPTOR AND HIV VIRAL BURDEN ON GUT MUCOSA$138,007
K24 · FY2004 · AI
Novel Pre-Clinical Mucosal Immunization Against HIV-1:$8,029
M01 · FY2004 · RR
Role of Immunization Site in Eliciting Mucosal Immunity$381,250
R01 · FY2003 · AI
IMPACT OF CO-RECEPTOR AND HIV VIRAL BURDEN ON GUT MUCOSA$135,607
K24 · FY2003 · AI
Role of Immunization Site in Eliciting Mucosal Immunity$343,125
R01 · FY2002 · AI
IMPACT OF CO-RECEPTOR AND HIV VIRAL BURDEN ON GUT MUCOSA$132,321
K24 · FY2002 · AI
CORE--MUCOSAL IMMUNITY$129,540
P30 · FY2002 · AI
Role of Immunization Site in Eliciting Mucosal Immunity$382,396
R01 · FY2001 · AI
CORE--MUCOSAL IMMUNITY$129,540
P30 · FY2001 · AI
IMPACT OF CO-RECEPTOR AND HIV VIRAL BURDEN ON GUT MUCOSA$114,320
K24 · FY2001 · AI
CORE--MUCOSAL IMMUNITY$0
P30 · FY2001 · AI
CORE--MUCOSAL IMMUNITY$142,758
P30 · FY2000 · AI
IMPACT OF CO-RECEPTOR AND HIV VIRAL BURDEN ON GUT MUCOSA$116,238
K24 · FY2000 · AI